| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bc3843865aa622abe63c067fe231fc10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44f04d319aaa6e66f240244bc905f452 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-73 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-30 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate |
2011-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46509ba6c34332ab6788da98855654de
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f598e423856664e347abd15dfa2c73ca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba85a08eb23fccb088459d3c05a4835f |
| publicationDate |
2013-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20130058390-A |
| titleOfInvention |
Pharmaceutical composition for the prophylaxis or treatment of cancer caused by the overexpression of GIA11114 containing an anti-GIA11114 antibody as an active ingredient |
| abstract |
The present invention relates to a pharmaceutical composition for preventing or treating cancer caused by KIAA1114 overexpression containing an anti-KIAA1114 antibody as an active ingredient. The anti-KIAA1114 antibody of the present invention specifically binds to the extracellular domain of KIAA1114 protein, specifically reacts with various cancer cell lines, and has excellent ability to inhibit cancer cell metastasis in vivo in a lung metastatic animal model using KIAA1114 overexpressing cancer cell lines. . Therefore, the anti-KIAA1114 antibody of the present invention can be usefully used for the prevention or treatment of cancer caused by KIAA1114 overexpression, especially metastatic cancer. |
| priorityDate |
2011-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |